BioSpace News Archive

Amgen (NASDAQ: AMGN) today announced that new data from its expanding inflammation pipeline and marketed portfolio will be presented at the European Academy of Dermatology and Venereology (EADV) 30th Congress, which will take place virtually Sept. 29 – Oct. 2.

Therapeutic Solutions International, Inc., (OTC Markets: TSOI), announced today successful treatment of a United States Navy SEAL Veteran suffering from Chronic Traumatic Encephalopathy (CTE).

Medial EarlySign (earlysign.com), a pioneering company developing AI-based clinical predictive analytics, announced today the signing of a definitive partnership agreement with Roche Diagnostics International Ltd.

Kyowa Kirin Co., Ltd. (TSE:4151, President and CEO: Masashi Miyamoto, “Kyowa Kirin”), a global specialty pharmaceutical company creating innovative medical solutions utilizing the latest biotechnology, today announced detailed data from a Phase 2 study of KHK4083/AMG 451 will be highlighted in a late- breaking oral presentation at the European Academy of Dermatology and Venereology 30th Virtual Congress.

Taiho Oncology, Inc. which specializes in orally administered anti-cancer medicines and whose mission is to improve the lives of patients with cancer, their families and their caregivers, announced data presentations from several studies for two of its investigational agents at the European Society for Medical Oncology Congress 2021.

Navrogen, Inc., a privately held preclinical biotechnology company, announced today that it has entered into a Cooperative Research and Development Agreement (CRADA) with researchers at The United States Army Medical Research Institute of Infectious Diseases (USAMRIID).

Cycle Pharmaceuticals (Cycle) is pleased to announce the launch of its Boston-based support platform for rare disease patients, Cycle Vita™.

Medidata, a Dassault Systèmes company, and Labcorp Drug Development, a global company providing clinical laboratory and end-to-end drug development services, today announced they have entered into an agreement using the Medidata Sensor Cloud.

Miach Orthopaedics, Inc., a privately held company dedicated to developing bio-engineered surgical implants for connective tissue restoration, today announced the first patient has been treated in the company’s BEAR III study of the BEAR® Implant – the first medical technology to clinically demonstrate that it enables healing of a patient’s torn anterior cruciate ligament (ACL).

AbCellera (Nasdaq: ABCL), a technology company with a centralized operating system for next-generation antibody discovery, today announced it has acquired TetraGenetics, Inc. (TetraGenetics).